Prognostic role of EGR1 in breast cancer: a systematic review

키워드

참고문헌 (69)

1. Shah R, "Pathogenesis, prevention, diagnosis and treatment of breast cancer", World J Clin Oncol, 5, pp.283~298 (2014)
2. Ataollahi MR, "Breast cancer and associated factors : a review", J Med Life, 8(Spec Iss 4), pp.6~11 (2015)
3. Nunziato M, "A multigene panel beyond BRCA1", BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy : a pilot study, 2019, pp.1046, 154~162
4. Blaschke F, "Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis", Rev Endocr Metab Dis, 5, pp.249~254 (2004)
5. Myung DS, "Expression of early growth response-1 in colorectal cancer and its relation to tumor cell proliferation and apoptosis", Oncol Rep, 31, pp.788~794 (2014)
6. Ma Z, "EGR1‐mediated linc01503promotes cell cycle progression and tumorigenesis in gastric cancer", Cell Proliferation, 54, pp.e12922~ (2021)
7. Juanhong Zhao, "EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression", Genes & Genomics, 43(5), pp.459~470 (2021), 한국유전학회[DOI]
8. Ma S, "A novel regulatory loop miR-101", ANXA2, Carcinogenesis, pp.2021, 42[DOI]
9. Mohamad T, "EGR1interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma", Oncotarget, 9, pp.18084~18098 (2018)
10. Wei LL, "Egr-1suppresses breast cancer cells proliferation by arresting cell cycle progression via down-regulating CyclinDs", Int J Clin Exp Patho, 10, pp.10212~10222 (2017)
11. Baron V, "The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin", Cancer Gene Ther, 13, pp.115~124 (2006)
12. Ferraro B, "EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer", J Clin Oncol, 23, pp.1921~1926 (2005)
13. Zhang HH, "EGR1decreases the malignancy of human non-small cell lung carcinoma by regulating KRT18 expression", Sci Rep, 4, pp.5416~ (2014)
14. Min IM, "The transcription factor EGR1controls both the proliferation and localization of hematopoietic stem cells", Cell Stem Cell, 2, pp.380~391 (2008)
15. Chen DG, "Inhibition of EGR1inhibits glioma proliferation by targeting CCND1 promoter", J Exp Clin Canc Res, 36, pp.186~ (2017)
16. Tao WW, "Egr-1 enhances drug resistance of breast cancer by modulating MDR1 expression in a GGPPS-independent manner", Biomed Pharmacother, 67, pp.197~202 (2013)
17. Wong KM, "CTCF and EGR1suppress breast cancer cell migration through transcriptional control of Nm23-H1", Sci Rep, 11, pp.491~ (2021)
18. Hao L, "The role of early growth response family members 1-4 in prognostic value of breast cancer", Front Genet, 12, pp.809~ (2021)
19. Shajahan-Haq AN, "EGR1regulates cellular metabolism and survival in endocrine resistant breast cancer", Oncotarget, 8, pp.96865~96884 (2017)
20. Rhodes DR, "Oncomine 3. 0 : genes, pathways, and networks in a collection of 18, 000 cancer gene expression profiles", Neoplasia, 9, pp.166~180 (2007)
21. Rhodes DR, "ONCOMINE : a cancer microarray database and integrated data-mining platform", Neoplasia, 6, pp.1~6 (2004)
22. Saha SK, "Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes", Sci Rep, 8, pp.14806~ (2018)
23. Saha SK, "Systematic multiomics analysis of alterations in C1QBP mRNA expression and relevance for clinical outcomes in cancers", J Clin Med, 8, pp.513~ (2019)
24. Chandrashekar DS, "UALCAN : a portal for facilitating tumor subgroup gene expression and survival analyses", Neoplasia, 19, pp.649~658 (2017)
25. Goldman MJ, "Visualizing and interpreting cancer genomics data via the Xena platform", Nat Biotechnol, 38, pp.675~678 (2020)
26. Uhlen M, "A pathology atlas of the human cancer transcriptome", Science, 357, pp.eaan2507~ (2017)
27. Uhlen M, "Proteomics. Tissue-based map of the human proteome", Science, 347, pp.1260419~ (2015)
28. Crowe AR, "Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis : an integrated protocol", Bio Protoc, 9, pp.e3465~ (2019)
29. Diez-Villanueva A, "Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer", Epigenetics Chromatin, 8, pp.22~ (2015)
30. Saha SK, "Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer", J Clin Med, 8, pp.355~ (2019)
31. Tate JG, "COSMIC : the catalogue of somatic mutations in cancer", Nucleic Acids Res, 47, pp.D941~D947 (2019)
32. Cerami E, "The cBio cancer genomics portal : an open platform for exploring multidimensional cancer genomics data", Cancer Discov, 2, pp.401~404 (2012)
33. Gao J, "Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal", Sci Signal, 6, pp.11~ (2013)
34. Mizuno H, "Progno-Scan : a new database for meta-analysis of the prognostic value of genes", BMC Med Genomics, 2, pp.18~ (2009)
35. Nagy A, "Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets", Sci Rep, 8, pp.9227~ (2018)
36. Goldman M, "The UCSC Xena platform for cancer genomics data visualization and interpretation", BioRxiv 326470, ~ (2019)
37. Jézéquel P, "bc-GenEx-Miner 3. 0 : new mining module computes breast cancer gene expression correlation analyses", Database, 2013, pp.bas060~ (2013)
38. Havis E, "EGR1 transcription factor is a multifaceted regulator of matrix production in tendons and other connective tissues", Int J Mol Sci, 21, pp.1664~ (2020)
39. Magee N, "Role of early growth response 1 in liver metabolism and liver cancer", Hepatoma Res, 3, pp.268~ (2017)
40. Lohoff M, "Early growth response protein-1(Egr-1)is preferentially expressed in T helper type 2(Th2)cells and is involved in acute transcription of the Th2 cytokine interleukin-4", J Biol Chem, 285, pp.1643~1652 (2010)
41. Milbrandt J, "A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor", Science, 238, pp.797~799 (1987)
42. Duclot F, "The role of early growth response 1(EGR1)in brain plasticity and neuropsychiatric disorders", Front Behav Neurosci, 11, pp.35~ (2017)
43. Thiel G, "Regulation of life and death by the zinc finger transcription factor Egr-1", J Cell Physiol, 193, pp.287~292 (2002)
44. Egerod FL, "High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression", BMC Cancer, 9, pp.385~ (2009)
45. Gitenay D, "Is EGR1 a potential target for prostate cancer therapy?", Future Oncol, 5, pp.993~1003 (2009)
46. Lin M, "A combination hepatoma-targeted therapy based on nanotechnology : pHREEgr1-HSV-TK", 131 I-antiAFPMcAb-GCV, Sci Rep, pp.2016, 6[DOI]
47. Ma J, "Targeted knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated invasion of prostate cancer cells through suppressing EGR-1", NF-κB synergy, 2009, pp.284, 34600~34606
48. Maegawa M, "EGFR mutation up-regulates EGR1 expression through the ERK pathway", Anticancer Res, 29, pp.1111~1117 (2009)
49. Adamson E, "Egr1 signaling in prostate cancer", Cancer Biol Ther, 2, pp.617~622 (2003)
50. Curtis C, "The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups", Nature, 486, pp.346~352 (2012)
51. Liu J, "Concurrent downregulation of Egr-1 and gelsolin in the majority of human breast cancer cells", Cancer Genomics Proteomics, 4, pp.377~385 (2007)
52. Yamashita K, "Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma", Cancer Cell, 2, pp.485~495 (2002)
53. Ng JMK, "Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer", Int J Mol Sci, 16, pp.2472~2496 (2015)
54. Richter AM, "Aberrant promoter methylation of the tumour suppressor RASSF10 and its growth inhibitory function in breast cancer", Cancers, 8, pp.26~ (2016)
55. Martincorena I, "Somatic mutation in cancer and normal cells", Science, 349, pp.1483~1489 (2015)
56. Myung E, "Expression of early growth response-1 in human gastric cancer and its relationship with tumor cell behaviors and prognosis", Pathol Res Pract, 209, pp.692~699 (2013)
57. Kataoka F, "EGRI and FOSB gene expressions in cancer stroma are independent prognostic indicators for epithelial ovarian cancer receiving standard therapy", Genes Chromosomes Cancer, 51, pp.300~312 (2012)
58. Boulding T, "Differential roles for DUSP family members in epithelial-to-mesenchymal transition and cancer stem cell regulation in breast cancer", PLoS One, 11, pp.e0148065~ (2016)
59. Fang-Ming Chen, "The mitogen-activated protein kinase phosphatase-1 (MKP-1) gene is a potential methylation biomarker for malignancy of breast cancer", Experimental and Molecular Medicine, 44(5), pp.356~362 (2012), 생화학분자생물학회[DOI]
60. Shen Q, "Novel agents for the prevention of breast cancer : targeting transcription factors and signal transduction pathways", J Mammary Gland Biol Neoplasia, 8, pp.45~73 (2003)
61. Wagstaff SC, "Extracellular ATP activates multiple signalling pathways and potentiates growth factor-induced c-fos gene expression in MCF-7 breast cancer cells", Carcinogenesis, 21, pp.2175~2181 (2000)
62. Fisler DA, "Elucidating feed-forward apoptosis signatures in breast cancer datasets : Higher FOS expression associated with a better outcome", Oncol Lett, 16, pp.2757~2763 (2018)
63. Shen JL, "Role of DUSP1", MKP1 in tumorigenesis, tumor progression and therapy, 2016, pp.5, 2061~2068
64. Fang J, "DUSP1 enhances the chemoresistance of gallbladder cancer via the modulation of the p38 pathway and DNA damage", repair system, 2018, pp.16, 1869~1875
65. Lu CH, "cFos is critical for MCF-7 breast cancer cell growth", Oncogene, 24, pp.6516~6524 (2005)
66. Langer S, "Jun and Fos family protein expression in human breast cancer : Correlation of protein expression and clinicopathological parameters", Eur J Gynaecol Oncol, 27, pp.345~352 (2006)
67. Keun-Cheol Kim, "Increased Expression of FosB through Reactive Oxygen Species Accumulation Functions as Pro-Apoptotic Protein in Piperlongumine Treated MCF7 Breast Cancer Cells", Molecules and Cells, 42(12), pp.884~892 (2019), 한국분자세포생물학회[DOI]
68. Huang Y-T, "The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis", Oncotarget, 8, pp.9200~9215 (2017)
69. Hellinger JW, "Inhibition of CYR61-S100A4axis limits breast cancer invasion", Front Oncol, 9, pp.1074~ (2019)

관련 논문AI추천